Cetuximab: In the Treatment of Metastatic Colorectal Cancer

By Reynolds N.A.   Wagstaff A.J.  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 109-118

Adis International

Access to resources Recommend Favorite

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

By Vincenzi Bruno   Santini Daniele   Russo Antonio   Gavasci Michele   Battistoni Fabrizio   Dicuonzo Giordano   Rocci Laura   Rosaria Valerio Maria   Gebbia Nicola   Tonini Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 319-327

Future Medicine

Access to resources Recommend Favorite

Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere

By Sato Takeo   Hatate Kazuhiko   Ikeda Atsushi   Yamanashi Takahiro   Ozawa Heita   Onosato Wataru   Nakamura Takatoshi   Ihara Atsushi   Watanabe Masahiko  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1223-1228

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in metastatic colorectal cancer: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 6, 2004-06 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

Cetuximab survival benefit in colorectal cancer EPIC news

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite